Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-055633
Filing Date
2025-06-02
Accepted
2025-06-02 20:40:52
Documents
1
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2516320-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2516320-6_4seq1.xml 4 4404
  Complete submission text file 0001104659-25-055633.txt   6003
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Issuer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AZRIELI CENTER ROUND TOWER, 30TH FLOOR TEL AVIV L3 9701101
Business Address
Carter Denise P. (Reporting) CIK: 0001958621 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37846 | Film No.: 251016954